{"text": ["AbbVie", "(ABBV)", "Gains", "As", "Market", "Dips:", "What", "You", "Should", "Know"], "created_at": "2021-06-07 21:45:09"}
{"text": ["AbbVie's", "Ibrutinib/Venetoclax", "Combo", "Potentially", "Chemo-free,", "Fixed-Duration", "Treatment", "Option", "in", "Leukemia"], "created_at": "2021-06-07 18:07:06"}
{"text": ["CAPTIVATE", "Study", "Shows", "an", "IMBRUVICA\u00ae", "(ibrutinib)", "Plus", "VENCLEXTA\u00ae/VENCLYXTO\u00ae", "(venetoclax)", "Chemotherapy-Free", "Combination", "Has", "Potential", "to", "Provide", "Remission", "After", "Fixed-Duration", "Treatment", "for", "Chronic", "Lymphocytic", "Leukemia", "(CLL)"], "created_at": "2021-06-07 15:30:00"}
{"text": ["Health", "Canada", "Approves", "AbbVie's", "RINVOQ\u00ae", "(upadacitinib)", "for", "the", "Treatment", "of", "Adults", "with", "Active", "Psoriatic", "Arthritis"], "created_at": "2021-06-07 11:01:00"}
